                               SEQUENCE LISTING

<110> JANUX THERAPEUTICS, INC.
 
<120> MODIFIED BISPECIFIC T CELL RECEPTORS

<130> 52426-705.602

<140>
<141>

<150> 62/595,976
<151> 2017-12-07

<160> 62    

<170> PatentIn version 3.5

<210> 1
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(40) 
<223> This sequence may encompass 6-20 "Gly Ser" repeating units

<400> 1
Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
1               5                   10                  15      


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            20                  25                  30          


Gly Ser Gly Ser Gly Ser Gly Ser 
        35                  40  


<210> 2
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(39) 
<223> This sequence may encompass 4-13 "Gly Gly Ser"
      repeating units

<400> 2
Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
1               5                   10                  15      


Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
            20                  25                  30          


Ser Gly Gly Ser Gly Gly Ser 
        35                  


<210> 3
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(40) 
<223> This sequence may encompass 3-10 "Gly Gly Gly Ser"
      repeating units

<400> 3
Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
            20                  25                  30          


Gly Gly Gly Ser Gly Gly Gly Ser 
        35                  40  


<210> 4
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(40) 
<223> This sequence may encompass 2-8 "Gly Gly Gly Gly Ser"
      repeating units

<400> 4
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Gly Ser 
        35                  40  


<210> 5
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(40) 
<223> This sequence may encompass 12-40 residues

<400> 5
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            20                  25                  30          


Gly Gly Gly Gly Gly Gly Gly Gly 
        35                  40  


<210> 6
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(33) 
<223> This sequence may encompass 1-3 "Gly Gly Gly Ser Gly 
      Ser Gly Gly Gly Gly Ser" repeating units

<400> 6
Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly 
1               5                   10                  15      


Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly 
            20                  25                  30          


Ser 
    


<210> 7
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(33) 
<223> This sequence may encompass 1-3 "Gly Gly Gly Gly Gly
      Pro Gly Gly Gly Gly Pro" repeating units

<400> 7
Gly Gly Gly Gly Gly Pro Gly Gly Gly Gly Pro Gly Gly Gly Gly Gly 
1               5                   10                  15      


Pro Gly Gly Gly Gly Pro Gly Gly Gly Gly Gly Pro Gly Gly Gly Gly 
            20                  25                  30          


Pro 
    


<210> 8
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(36) 
<223> This sequence may encompass 2-6 "Gly Gly Ser Gly Gly Asp"
      repeating units 

<400> 8
Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly 
1               5                   10                  15      


Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly 
            20                  25                  30          


Ser Gly Gly Asp 
        35      


<210> 9
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(36) 
<223> This sequence may encompass 2-6 "Gly Gly Ser Gly Gly Glu"
      repeating units 

<400> 9
Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly 
1               5                   10                  15      


Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly 
            20                  25                  30          


Ser Gly Gly Glu 
        35      


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Pro Arg Phe Lys Ile Ile Gly Gly 
1               5               


<210> 11
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Pro Arg Phe Arg Ile Ile Gly Gly 
1               5               


<210> 12
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Ser Ser Arg His Arg Arg Ala Leu Asp 
1               5                   


<210> 13
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Arg Lys Ser Ser Ile Ile Ile Arg Met Arg Asp Val Val Leu 
1               5                   10                  


<210> 14
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ser Ser Ser Phe Asp Lys Gly Lys Tyr Lys Lys Gly Asp Asp Ala 
1               5                   10                  15  


<210> 15
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ser Ser Ser Phe Asp Lys Gly Lys Tyr Lys Arg Gly Asp Asp Ala 
1               5                   10                  15  


<210> 16
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Ile Glu Gly Arg 
1               


<210> 17
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Ile Asp Gly Arg 
1               


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Gly Gly Ser Ile Asp Gly Arg 
1               5           


<210> 19
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Pro Leu Gly Leu Trp Ala 
1               5       


<210> 20
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Gly Pro Gln Gly Ile Ala Gly Gln 
1               5               


<210> 21
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Gly Pro Gln Gly Leu Leu Gly Ala 
1               5               


<210> 22
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Gly Ile Ala Gly Gln 
1               5   


<210> 23
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Gly Pro Leu Gly Ile Ala Gly Ile 
1               5               


<210> 24
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (26)..(26)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (28)..(28)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (30)..(30)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (32)..(32)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (34)..(34)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (36)..(36)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (38)..(38)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (40)..(40)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 24
Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa 
1               5                   10                  15      


Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa 
            20                  25                  30          


Gly Xaa Gly Xaa Gly Xaa Gly Xaa 
        35                  40  


<210> 25
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (30)..(30)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (33)..(33)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (36)..(36)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (39)..(39)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 25
Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly 
1               5                   10                  15      


Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly 
            20                  25                  30          


Xaa Gly Gly Xaa Gly Gly Xaa 
        35                  


<210> 26
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (28)..(28)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (32)..(32)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (36)..(36)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (40)..(40)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 26
Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa 
1               5                   10                  15      


Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa 
            20                  25                  30          


Gly Gly Gly Xaa Gly Gly Gly Xaa 
        35                  40  


<210> 27
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (30)..(30)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (35)..(35)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (40)..(40)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 27
Gly Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly 
1               5                   10                  15      


Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly Gly 
            20                  25                  30          


Gly Gly Xaa Gly Gly Gly Gly Xaa 
        35                  40  


<210> 28
<211> 315
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(20)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (22)..(41)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (42)..(42)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (43)..(62)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (63)..(63)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (64)..(83)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (84)..(84)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (85)..(104)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (105)..(105)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (106)..(125)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (126)..(126)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (127)..(146)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (147)..(147)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (148)..(167)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (168)..(168)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (169)..(188)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (189)..(189)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (190)..(209)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (210)..(210)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (211)..(230)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (231)..(231)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (232)..(251)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (252)..(252)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (253)..(272)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (273)..(273)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (274)..(293)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (294)..(294)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MISC_FEATURE
<222> (295)..(314)
<223> This region may encompass 1-20 residues

<220>
<221> MOD_RES
<222> (315)..(315)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 28
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            20                  25                  30          


Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly 
        35                  40                  45              


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly 
    50                  55                  60                  


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
65                  70                  75                  80  


Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
                85                  90                  95      


Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly 
            100                 105                 110         


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly 
        115                 120                 125             


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
    130                 135                 140                 


Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
145                 150                 155                 160 


Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly 
                165                 170                 175     


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly 
            180                 185                 190         


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
        195                 200                 205             


Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
    210                 215                 220                 


Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly 
225                 230                 235                 240 


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly 
                245                 250                 255     


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            260                 265                 270         


Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
        275                 280                 285             


Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
    290                 295                 300                 


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa 
305                 310                 315 


<210> 29
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Gly Pro Glu Gly Leu Arg Val Gly 
1               5               


<210> 30
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Tyr Gly Ala Gly Leu Gly Val Val 
1               5               


<210> 31
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Ala Gly Leu Gly Val Val Glu Arg 
1               5               


<210> 32
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Ala Gly Leu Gly Ile Ser Ser Thr 
1               5               


<210> 33
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Glu Pro Gln Ala Leu Ala Met Ser 
1               5               


<210> 34
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Gln Ala Leu Ala Met Ser Ala Ile 
1               5               


<210> 35
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Ala Ala Tyr His Leu Val Ser Gln 
1               5               


<210> 36
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Met Asp Ala Phe Leu Glu Ser Ser 
1               5               


<210> 37
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Glu Ser Leu Pro Val Val Ala Val 
1               5               


<210> 38
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Ser Ala Pro Ala Val Glu Ser Glu 
1               5               


<210> 39
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 39
Asp Val Ala Gln Phe Val Leu Thr 
1               5               


<210> 40
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Gly Leu Leu Val Ala Gly Val Leu Val Leu Leu Val Ser Leu Gly Val 
1               5                   10                  15      


Ala Ile His Leu Cys Cys 
            20          


<210> 41
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 41
Ala Leu Ile Val Leu Gly Gly Val Ala Gly Leu Leu Leu Phe Ile Gly 
1               5                   10                  15      


Leu Gly Ile Phe Phe Cys Val Arg Cys 
            20                  25  


<210> 42
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 42
Leu Cys Tyr Leu Leu Asp Gly Ile Leu Phe Ile Tyr Gly Val Ile Leu 
1               5                   10                  15      


Thr Ala Leu Phe Leu Arg Val 
            20              


<210> 43
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 43
Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu Leu 
1               5                   10                  15      


Val Thr Val Ala Phe Ile Ile Phe Trp Val 
            20                  25      


<210> 44
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 44
Ala Ala Ile Leu Gly Leu Gly Leu Val Leu Gly Leu Leu Gly Pro Leu 
1               5                   10                  15      


Ala Ile Leu Leu Ala Leu Tyr Leu Leu 
            20                  25  


<210> 45
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 45
Ala Leu Pro Ala Ala Leu Ala Val Ile Ser Phe Leu Leu Gly Leu Gly 
1               5                   10                  15      


Leu Gly Val Ala Cys Val Leu Ala 
            20                  


<210> 46
<211> 218
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 46
Met Gln Glu Val Thr Gln Ile Pro Ala Ala Leu Ser Val Pro Glu Gly 
1               5                   10                  15      


Glu Asn Leu Val Leu Asn Cys Ser Phe Thr Asp Ser Ala Ile Tyr Asn 
            20                  25                  30          


Leu Gln Trp Phe Arg Gln Asp Pro Gly Lys Gly Leu Thr Ser Leu Leu 
        35                  40                  45              


Tyr Val Arg Pro Tyr Gln Arg Glu Gln Thr Ser Gly Arg Leu Asn Ala 
    50                  55                  60                  


Ser Leu Asp Lys Ser Ser Gly Arg Ser Thr Leu Tyr Ile Ala Ala Ser 
65                  70                  75                  80  


Gln Pro Gly Asp Ser Ala Thr Tyr Leu Cys Ala Val Arg Pro Gly Gly 
                85                  90                  95      


Ala Gly Pro Phe Phe Val Val Phe Gly Lys Gly Thr Lys Leu Ser Val 
            100                 105                 110         


Ile Pro Asn Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp 
        115                 120                 125             


Ser Lys Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser 
    130                 135                 140                 


Gln Thr Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr Asp 
145                 150                 155                 160 


Lys Cys Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser Asn Ser Ala 
                165                 170                 175     


Val Ala Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe Asn 
            180                 185                 190         


Asn Ser Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser Ser 
        195                 200                 205             


Gly Gly His His His His His His His His 
    210                 215             


<210> 47
<211> 260
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 47
Met Lys Ala Gly Val Thr Gln Thr Pro Arg Tyr Leu Ile Lys Thr Arg 
1               5                   10                  15      


Gly Gln Gln Val Thr Leu Ser Cys Ser Pro Ile Ser Gly His Arg Ser 
            20                  25                  30          


Val Ser Trp Tyr Gln Gln Thr Pro Gly Gln Gly Leu Gln Phe Leu Phe 
        35                  40                  45              


Glu Tyr Phe Ser Glu Thr Gln Arg Asn Lys Gly Asn Phe Pro Gly Arg 
    50                  55                  60                  


Phe Ser Gly Arg Gln Phe Ser Asn Ser Arg Ser Glu Met Asn Val Ser 
65                  70                  75                  80  


Thr Leu Glu Leu Gly Asp Ser Ala Leu Tyr Leu Cys Ala Ser Ser Phe 
                85                  90                  95      


Asn Met Ala Thr Gly Gln Tyr Phe Gly Pro Gly Thr Arg Leu Thr Val 
            100                 105                 110         


Thr Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val Phe Glu 
        115                 120                 125             


Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu Val Cys 
    130                 135                 140                 


Leu Ala Thr Gly Phe Tyr Pro Asp His Val Glu Leu Ser Trp Trp Val 
145                 150                 155                 160 


Asn Gly Lys Glu Val His Ser Gly Val Cys Thr Asp Pro Gln Pro Leu 
                165                 170                 175     


Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Ala Leu Ser Ser Arg 
            180                 185                 190         


Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His Phe Arg 
        195                 200                 205             


Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln 
    210                 215                 220                 


Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala Trp Gly 
225                 230                 235                 240 


Arg Ala Asp Gly Gly Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile 
                245                 250                 255     


Glu Trp His Glu 
            260 


<210> 48
<211> 518
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 48
Met Lys Ala Gly Val Thr Gln Thr Pro Arg Tyr Leu Ile Lys Thr Arg 
1               5                   10                  15      


Gly Gln Gln Val Thr Leu Ser Cys Ser Pro Ile Ser Gly His Arg Ser 
            20                  25                  30          


Val Ser Trp Tyr Gln Gln Thr Pro Gly Gln Gly Leu Gln Phe Leu Phe 
        35                  40                  45              


Glu Tyr Phe Ser Glu Thr Gln Arg Asn Lys Gly Asn Phe Pro Gly Arg 
    50                  55                  60                  


Phe Ser Gly Arg Gln Phe Ser Asn Ser Arg Ser Glu Met Asn Val Ser 
65                  70                  75                  80  


Thr Leu Glu Leu Gly Asp Ser Ala Leu Tyr Leu Cys Ala Ser Ser Phe 
                85                  90                  95      


Asn Met Ala Thr Gly Gln Tyr Phe Gly Pro Gly Thr Arg Leu Thr Val 
            100                 105                 110         


Thr Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val Phe Glu 
        115                 120                 125             


Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu Val Cys 
    130                 135                 140                 


Leu Ala Thr Gly Phe Tyr Pro Asp His Val Glu Leu Ser Trp Trp Val 
145                 150                 155                 160 


Asn Gly Lys Glu Val His Ser Gly Val Cys Thr Asp Pro Gln Pro Leu 
                165                 170                 175     


Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Ala Leu Ser Ser Arg 
            180                 185                 190         


Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His Phe Arg 
        195                 200                 205             


Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln 
    210                 215                 220                 


Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala Trp Gly 
225                 230                 235                 240 


Arg Ala Asp Gly Gly Gly Gly Ser Ala Ile Gln Met Thr Gln Ser Pro 
                245                 250                 255     


Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg 
            260                 265                 270         


Ala Ser Gln Asp Ile Arg Asn Tyr Leu Asn Trp Tyr Gln Gln Lys Pro 
        275                 280                 285             


Gly Lys Ala Pro Lys Leu Leu Ile Tyr Tyr Thr Ser Arg Leu Glu Ser 
    290                 295                 300                 


Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr 
305                 310                 315                 320 


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
                325                 330                 335     


Gln Gln Gly Asn Thr Leu Pro Trp Thr Phe Gly Gln Gly Thr Lys Val 
            340                 345                 350         


Glu Ile Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        355                 360                 365             


Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Glu Val Gln Leu Val 
    370                 375                 380                 


Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser 
385                 390                 395                 400 


Cys Ala Ala Ser Gly Tyr Ser Phe Thr Gly Tyr Thr Met Asn Trp Val 
                405                 410                 415     


Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Leu Ile Asn Pro 
            420                 425                 430         


Tyr Lys Gly Val Ser Thr Tyr Asn Gln Lys Phe Lys Asp Arg Phe Thr 
        435                 440                 445             


Ile Ser Val Asp Lys Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser 
    450                 455                 460                 


Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Gly Tyr 
465                 470                 475                 480 


Tyr Gly Asp Ser Asp Trp Tyr Phe Asp Val Trp Gly Gln Gly Thr Leu 
                485                 490                 495     


Val Thr Val Ser Ser Gly Gly Gly Leu Asn Asp Ile Phe Glu Ala Gln 
            500                 505                 510         


Lys Ile Glu Trp His Glu 
        515             


<210> 49
<211> 560
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 49
Met Gly Gly Val Ser Cys Lys Asp Val Tyr Asp Glu Ala Phe Cys Trp 
1               5                   10                  15      


Thr Gly Gly Gly Gly Ser Ser Gly Gly Ser Gly Gly Ser Gly Leu Ser 
            20                  25                  30          


Gly Arg Ser Asp Asn His Gly Ser Ser Gly Thr Lys Ala Gly Val Thr 
        35                  40                  45              


Gln Thr Pro Arg Tyr Leu Ile Lys Thr Arg Gly Gln Gln Val Thr Leu 
    50                  55                  60                  


Ser Cys Ser Pro Ile Ser Gly His Arg Ser Val Ser Trp Tyr Gln Gln 
65                  70                  75                  80  


Thr Pro Gly Gln Gly Leu Gln Phe Leu Phe Glu Tyr Phe Ser Glu Thr 
                85                  90                  95      


Gln Arg Asn Lys Gly Asn Phe Pro Gly Arg Phe Ser Gly Arg Gln Phe 
            100                 105                 110         


Ser Asn Ser Arg Ser Glu Met Asn Val Ser Thr Leu Glu Leu Gly Asp 
        115                 120                 125             


Ser Ala Leu Tyr Leu Cys Ala Ser Ser Phe Asn Met Ala Thr Gly Gln 
    130                 135                 140                 


Tyr Phe Gly Pro Gly Thr Arg Leu Thr Val Thr Glu Asp Leu Lys Asn 
145                 150                 155                 160 


Val Phe Pro Pro Glu Val Ala Val Phe Glu Pro Ser Glu Ala Glu Ile 
                165                 170                 175     


Ser His Thr Gln Lys Ala Thr Leu Val Cys Leu Ala Thr Gly Phe Tyr 
            180                 185                 190         


Pro Asp His Val Glu Leu Ser Trp Trp Val Asn Gly Lys Glu Val His 
        195                 200                 205             


Ser Gly Val Cys Thr Asp Pro Gln Pro Leu Lys Glu Gln Pro Ala Leu 
    210                 215                 220                 


Asn Asp Ser Arg Tyr Ala Leu Ser Ser Arg Leu Arg Val Ser Ala Thr 
225                 230                 235                 240 


Phe Trp Gln Asn Pro Arg Asn His Phe Arg Cys Gln Val Gln Phe Tyr 
                245                 250                 255     


Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln Asp Arg Ala Lys Pro Val 
            260                 265                 270         


Thr Gln Ile Val Ser Ala Glu Ala Trp Gly Arg Ala Asp Gly Gly Gly 
        275                 280                 285             


Gly Ser Ala Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser 
    290                 295                 300                 


Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Arg 
305                 310                 315                 320 


Asn Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu 
                325                 330                 335     


Leu Ile Tyr Tyr Thr Ser Arg Leu Glu Ser Gly Val Pro Ser Arg Phe 
            340                 345                 350         


Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Leu Thr Ile Ser Ser Leu 
        355                 360                 365             


Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Asn Thr Leu 
    370                 375                 380                 


Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Gly Gly Gly 
385                 390                 395                 400 


Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
                405                 410                 415     


Ser Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu 
            420                 425                 430         


Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr 
        435                 440                 445             


Ser Phe Thr Gly Tyr Thr Met Asn Trp Val Arg Gln Ala Pro Gly Lys 
    450                 455                 460                 


Gly Leu Glu Trp Val Ala Leu Ile Asn Pro Tyr Lys Gly Val Ser Thr 
465                 470                 475                 480 


Tyr Asn Gln Lys Phe Lys Asp Arg Phe Thr Ile Ser Val Asp Lys Ser 
                485                 490                 495     


Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr 
            500                 505                 510         


Ala Val Tyr Tyr Cys Ala Arg Ser Gly Tyr Tyr Gly Asp Ser Asp Trp 
        515                 520                 525             


Tyr Phe Asp Val Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly 
    530                 535                 540                 


Gly Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
545                 550                 555                 560 


<210> 50
<211> 518
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 50
Met Ala Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val 
1               5                   10                  15      


Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Arg Asn 
            20                  25                  30          


Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Tyr Thr Ser Arg Leu Glu Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Tyr Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Asn Thr Leu Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Gly Gly Gly Gly 
            100                 105                 110         


Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val 
    130                 135                 140                 


Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser 
145                 150                 155                 160 


Phe Thr Gly Tyr Thr Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly 
                165                 170                 175     


Leu Glu Trp Val Ala Leu Ile Asn Pro Tyr Lys Gly Val Ser Thr Tyr 
            180                 185                 190         


Asn Gln Lys Phe Lys Asp Arg Phe Thr Ile Ser Val Asp Lys Ser Lys 
        195                 200                 205             


Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala 
    210                 215                 220                 


Val Tyr Tyr Cys Ala Arg Ser Gly Tyr Tyr Gly Asp Ser Asp Trp Tyr 
225                 230                 235                 240 


Phe Asp Val Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly 
                245                 250                 255     


Gly Gly Ser Lys Ala Gly Val Thr Gln Thr Pro Arg Tyr Leu Ile Lys 
            260                 265                 270         


Thr Arg Gly Gln Gln Val Thr Leu Ser Cys Ser Pro Ile Ser Gly His 
        275                 280                 285             


Arg Ser Val Ser Trp Tyr Gln Gln Thr Pro Gly Gln Gly Leu Gln Phe 
    290                 295                 300                 


Leu Phe Glu Tyr Phe Ser Glu Thr Gln Arg Asn Lys Gly Asn Phe Pro 
305                 310                 315                 320 


Gly Arg Phe Ser Gly Arg Gln Phe Ser Asn Ser Arg Ser Glu Met Asn 
                325                 330                 335     


Val Ser Thr Leu Glu Leu Gly Asp Ser Ala Leu Tyr Leu Cys Ala Ser 
            340                 345                 350         


Ser Phe Asn Met Ala Thr Gly Gln Tyr Phe Gly Pro Gly Thr Arg Leu 
        355                 360                 365             


Thr Val Thr Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val 
    370                 375                 380                 


Phe Glu Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu 
385                 390                 395                 400 


Val Cys Leu Ala Thr Gly Phe Tyr Pro Asp His Val Glu Leu Ser Trp 
                405                 410                 415     


Trp Val Asn Gly Lys Glu Val His Ser Gly Val Cys Thr Asp Pro Gln 
            420                 425                 430         


Pro Leu Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Ala Leu Ser 
        435                 440                 445             


Ser Arg Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His 
    450                 455                 460                 


Phe Arg Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp 
465                 470                 475                 480 


Thr Gln Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala 
                485                 490                 495     


Trp Gly Arg Ala Asp Gly Gly Gly Leu Asn Asp Ile Phe Glu Ala Gln 
            500                 505                 510         


Lys Ile Glu Trp His Glu 
        515             


<210> 51
<211> 253
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 51
Met Gly Gly Val Ser Cys Lys Asp Val Tyr Asp Glu Ala Phe Cys Trp 
1               5                   10                  15      


Thr Gly Gly Gly Gly Ser Leu Ser Gly Arg Ser Asp Asn His Gly Ser 
            20                  25                  30          


Ser Gly Thr Lys Gln Glu Val Thr Gln Ile Pro Ala Ala Leu Ser Val 
        35                  40                  45              


Pro Glu Gly Glu Asn Leu Val Leu Asn Cys Ser Phe Thr Asp Ser Ala 
    50                  55                  60                  


Ile Tyr Asn Leu Gln Trp Phe Arg Gln Asp Pro Gly Lys Gly Leu Thr 
65                  70                  75                  80  


Ser Leu Leu Tyr Val Arg Pro Tyr Gln Arg Glu Gln Thr Ser Gly Arg 
                85                  90                  95      


Leu Asn Ala Ser Leu Asp Lys Ser Ser Gly Arg Ser Thr Leu Tyr Ile 
            100                 105                 110         


Ala Ala Ser Gln Pro Gly Asp Ser Ala Thr Tyr Leu Cys Ala Val Arg 
        115                 120                 125             


Pro Gly Gly Ala Gly Pro Phe Phe Val Val Phe Gly Lys Gly Thr Lys 
    130                 135                 140                 


Leu Ser Val Ile Pro Asn Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln 
145                 150                 155                 160 


Leu Arg Asp Ser Lys Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp 
                165                 170                 175     


Phe Asp Ser Gln Thr Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr 
            180                 185                 190         


Ile Thr Asp Lys Cys Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser 
        195                 200                 205             


Asn Ser Ala Val Ala Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn 
    210                 215                 220                 


Ala Phe Asn Asn Ser Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro 
225                 230                 235                 240 


Glu Ser Ser Gly Gly His His His His His His His His 
                245                 250             


<210> 52
<211> 261
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 52
Met Gly Gly Val Ser Cys Lys Asp Val Tyr Asp Glu Ala Phe Cys Trp 
1               5                   10                  15      


Thr Gly Gly Gly Gly Ser Ser Gly Gly Ser Gly Gly Ser Gly Leu Ser 
            20                  25                  30          


Gly Arg Ser Asp Asn His Gly Ser Ser Gly Thr Lys Gln Glu Val Thr 
        35                  40                  45              


Gln Ile Pro Ala Ala Leu Ser Val Pro Glu Gly Glu Asn Leu Val Leu 
    50                  55                  60                  


Asn Cys Ser Phe Thr Asp Ser Ala Ile Tyr Asn Leu Gln Trp Phe Arg 
65                  70                  75                  80  


Gln Asp Pro Gly Lys Gly Leu Thr Ser Leu Leu Tyr Val Arg Pro Tyr 
                85                  90                  95      


Gln Arg Glu Gln Thr Ser Gly Arg Leu Asn Ala Ser Leu Asp Lys Ser 
            100                 105                 110         


Ser Gly Arg Ser Thr Leu Tyr Ile Ala Ala Ser Gln Pro Gly Asp Ser 
        115                 120                 125             


Ala Thr Tyr Leu Cys Ala Val Arg Pro Gly Gly Ala Gly Pro Phe Phe 
    130                 135                 140                 


Val Val Phe Gly Lys Gly Thr Lys Leu Ser Val Ile Pro Asn Ile Gln 
145                 150                 155                 160 


Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp Ser Lys Ser Ser Asp 
                165                 170                 175     


Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser Gln Thr Asn Val Ser 
            180                 185                 190         


Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr Asp Lys Cys Val Leu Asp 
        195                 200                 205             


Met Arg Ser Met Asp Phe Lys Ser Asn Ser Ala Val Ala Trp Ser Asn 
    210                 215                 220                 


Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe Asn Asn Ser Ile Ile Pro 
225                 230                 235                 240 


Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser Ser Gly Gly His His His 
                245                 250                 255     


His His His His His 
            260     


<210> 53
<211> 477
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 53
Met Ala Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val 
1               5                   10                  15      


Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Arg Asn 
            20                  25                  30          


Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Tyr Thr Ser Arg Leu Glu Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Tyr Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Asn Thr Leu Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Gly Gly Gly Gly 
            100                 105                 110         


Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
        115                 120                 125             


Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val 
    130                 135                 140                 


Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Ser 
145                 150                 155                 160 


Phe Thr Gly Tyr Thr Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly 
                165                 170                 175     


Leu Glu Trp Val Ala Leu Ile Asn Pro Tyr Lys Gly Val Ser Thr Tyr 
            180                 185                 190         


Asn Gln Lys Phe Lys Asp Arg Phe Thr Ile Ser Val Asp Lys Ser Lys 
        195                 200                 205             


Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala 
    210                 215                 220                 


Val Tyr Tyr Cys Ala Arg Ser Gly Tyr Tyr Gly Asp Ser Asp Trp Tyr 
225                 230                 235                 240 


Phe Asp Val Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly 
                245                 250                 255     


Gly Gly Ser Lys Gln Glu Val Thr Gln Ile Pro Ala Ala Leu Ser Val 
            260                 265                 270         


Pro Glu Gly Glu Asn Leu Val Leu Asn Cys Ser Phe Thr Asp Ser Ala 
        275                 280                 285             


Ile Tyr Asn Leu Gln Trp Phe Arg Gln Asp Pro Gly Lys Gly Leu Thr 
    290                 295                 300                 


Ser Leu Leu Tyr Val Arg Pro Tyr Gln Arg Glu Gln Thr Ser Gly Arg 
305                 310                 315                 320 


Leu Asn Ala Ser Leu Asp Lys Ser Ser Gly Arg Ser Thr Leu Tyr Ile 
                325                 330                 335     


Ala Ala Ser Gln Pro Gly Asp Ser Ala Thr Tyr Leu Cys Ala Val Arg 
            340                 345                 350         


Pro Gly Gly Ala Gly Pro Phe Phe Val Val Phe Gly Lys Gly Thr Lys 
        355                 360                 365             


Leu Ser Val Ile Pro Asn Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln 
    370                 375                 380                 


Leu Arg Asp Ser Lys Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp 
385                 390                 395                 400 


Phe Asp Ser Gln Thr Asn Val Ser Gln Ser Lys Asp Ser Asp Val Tyr 
                405                 410                 415     


Ile Thr Asp Lys Cys Val Leu Asp Met Arg Ser Met Asp Phe Lys Ser 
            420                 425                 430         


Asn Ser Ala Val Ala Trp Ser Asn Lys Ser Asp Phe Ala Cys Ala Asn 
        435                 440                 445             


Ala Phe Asn Asn Ser Ile Ile Pro Glu Asp Thr Phe Phe Pro Ser Pro 
    450                 455                 460                 


Glu Ser Ser Gly Gly His His His His His His His His 
465                 470                 475         


<210> 54
<211> 260
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 54
Met Lys Ala Gly Val Thr Gln Thr Pro Arg Tyr Leu Ile Lys Thr Arg 
1               5                   10                  15      


Gly Gln Gln Val Thr Leu Ser Cys Ser Pro Ile Ser Gly His Arg Ser 
            20                  25                  30          


Val Ser Trp Tyr Gln Gln Thr Pro Gly Gln Gly Leu Gln Phe Leu Phe 
        35                  40                  45              


Glu Tyr Phe Ser Glu Thr Gln Arg Asn Lys Gly Asn Phe Pro Gly Arg 
    50                  55                  60                  


Phe Ser Gly Arg Gln Phe Ser Asn Ser Arg Ser Glu Met Asn Val Ser 
65                  70                  75                  80  


Thr Leu Glu Leu Gly Asp Ser Ala Leu Tyr Leu Cys Ala Ser Ser Phe 
                85                  90                  95      


Asn Met Ala Thr Gly Gln Tyr Phe Gly Pro Gly Thr Arg Leu Thr Val 
            100                 105                 110         


Thr Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val Phe Glu 
        115                 120                 125             


Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu Val Cys 
    130                 135                 140                 


Leu Ala Thr Gly Phe Tyr Pro Asp His Val Glu Leu Ser Trp Trp Val 
145                 150                 155                 160 


Asn Gly Lys Glu Val His Ser Gly Val Cys Thr Asp Pro Gln Pro Leu 
                165                 170                 175     


Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Ala Leu Ser Ser Arg 
            180                 185                 190         


Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His Phe Arg 
        195                 200                 205             


Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln 
    210                 215                 220                 


Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala Trp Gly 
225                 230                 235                 240 


Arg Ala Asp Gly Gly Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile 
                245                 250                 255     


Glu Trp His Glu 
            260 


<210> 55
<211> 294
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 55
Met Gly Gly Val Ser Cys Lys Asp Val Tyr Asp Glu Ala Phe Cys Trp 
1               5                   10                  15      


Thr Gly Gly Gly Gly Ser Leu Ser Gly Arg Ser Asp Asn His Gly Ser 
            20                  25                  30          


Ser Gly Thr Lys Ala Gly Val Thr Gln Thr Pro Arg Tyr Leu Ile Lys 
        35                  40                  45              


Thr Arg Gly Gln Gln Val Thr Leu Ser Cys Ser Pro Ile Ser Gly His 
    50                  55                  60                  


Arg Ser Val Ser Trp Tyr Gln Gln Thr Pro Gly Gln Gly Leu Gln Phe 
65                  70                  75                  80  


Leu Phe Glu Tyr Phe Ser Glu Thr Gln Arg Asn Lys Gly Asn Phe Pro 
                85                  90                  95      


Gly Arg Phe Ser Gly Arg Gln Phe Ser Asn Ser Arg Ser Glu Met Asn 
            100                 105                 110         


Val Ser Thr Leu Glu Leu Gly Asp Ser Ala Leu Tyr Leu Cys Ala Ser 
        115                 120                 125             


Ser Phe Asn Met Ala Thr Gly Gln Tyr Phe Gly Pro Gly Thr Arg Leu 
    130                 135                 140                 


Thr Val Thr Glu Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val 
145                 150                 155                 160 


Phe Glu Pro Ser Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu 
                165                 170                 175     


Val Cys Leu Ala Thr Gly Phe Tyr Pro Asp His Val Glu Leu Ser Trp 
            180                 185                 190         


Trp Val Asn Gly Lys Glu Val His Ser Gly Val Cys Thr Asp Pro Gln 
        195                 200                 205             


Pro Leu Lys Glu Gln Pro Ala Leu Asn Asp Ser Arg Tyr Ala Leu Ser 
    210                 215                 220                 


Ser Arg Leu Arg Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His 
225                 230                 235                 240 


Phe Arg Cys Gln Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp 
                245                 250                 255     


Thr Gln Asp Arg Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala 
            260                 265                 270         


Trp Gly Arg Ala Asp Gly Gly Gly Leu Asn Asp Ile Phe Glu Ala Gln 
        275                 280                 285             


Lys Ile Glu Trp His Glu 
    290                 


<210> 56
<211> 302
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 56
Met Gly Gly Val Ser Cys Lys Asp Val Tyr Asp Glu Ala Phe Cys Trp 
1               5                   10                  15      


Thr Gly Gly Gly Gly Ser Ser Gly Gly Ser Gly Gly Ser Gly Leu Ser 
            20                  25                  30          


Gly Arg Ser Asp Asn His Gly Ser Ser Gly Thr Lys Ala Gly Val Thr 
        35                  40                  45              


Gln Thr Pro Arg Tyr Leu Ile Lys Thr Arg Gly Gln Gln Val Thr Leu 
    50                  55                  60                  


Ser Cys Ser Pro Ile Ser Gly His Arg Ser Val Ser Trp Tyr Gln Gln 
65                  70                  75                  80  


Thr Pro Gly Gln Gly Leu Gln Phe Leu Phe Glu Tyr Phe Ser Glu Thr 
                85                  90                  95      


Gln Arg Asn Lys Gly Asn Phe Pro Gly Arg Phe Ser Gly Arg Gln Phe 
            100                 105                 110         


Ser Asn Ser Arg Ser Glu Met Asn Val Ser Thr Leu Glu Leu Gly Asp 
        115                 120                 125             


Ser Ala Leu Tyr Leu Cys Ala Ser Ser Phe Asn Met Ala Thr Gly Gln 
    130                 135                 140                 


Tyr Phe Gly Pro Gly Thr Arg Leu Thr Val Thr Glu Asp Leu Lys Asn 
145                 150                 155                 160 


Val Phe Pro Pro Glu Val Ala Val Phe Glu Pro Ser Glu Ala Glu Ile 
                165                 170                 175     


Ser His Thr Gln Lys Ala Thr Leu Val Cys Leu Ala Thr Gly Phe Tyr 
            180                 185                 190         


Pro Asp His Val Glu Leu Ser Trp Trp Val Asn Gly Lys Glu Val His 
        195                 200                 205             


Ser Gly Val Cys Thr Asp Pro Gln Pro Leu Lys Glu Gln Pro Ala Leu 
    210                 215                 220                 


Asn Asp Ser Arg Tyr Ala Leu Ser Ser Arg Leu Arg Val Ser Ala Thr 
225                 230                 235                 240 


Phe Trp Gln Asn Pro Arg Asn His Phe Arg Cys Gln Val Gln Phe Tyr 
                245                 250                 255     


Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln Asp Arg Ala Lys Pro Val 
            260                 265                 270         


Thr Gln Ile Val Ser Ala Glu Ala Trp Gly Arg Ala Asp Gly Gly Gly 
        275                 280                 285             


Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
    290                 295                 300         


<210> 57
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(4)
<223> Any amino acid

<400> 57
Tyr Asp Xaa Xaa Phe 
1               5   


<210> 58
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 58
Asp Val Tyr Asp Glu Ala Phe 
1               5           


<210> 59
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 59
Gly Gly Val Ser Cys Lys Asp Val Tyr Asp Glu Ala Phe Cys Trp Thr 
1               5                   10                  15      


<210> 60
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 60
Gly Gly Gly Gly Ser Leu Ser Gly Arg Ser Asp Asn His Gly Ser Ser 
1               5                   10                  15      


Gly Thr 
        


<210> 61
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 61
Gly Gly Gly Gly Ser Ser Gly Gly Ser Gly Gly Ser Gly Leu Ser Gly 
1               5                   10                  15      


Arg Ser Asp Asn His Gly Ser Ser Gly Thr 
            20                  25      


<210> 62
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(9)
<223> This sequence may encompass 1-3 "Gly Gly Ser"
      repeating units

<400> 62
Gly Gly Ser Gly Gly Ser Gly Gly Ser 
1               5                   



